2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Sell
36
IPHA Quote, Financials, Valuation and Earnings
Last price:
$2.10
Seasonality move
:
-9.3%
Day range:
$2.06 - $2.21
52-week range:
$1.29 - $3.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.11x
P/B ratio:
21.96x
Volume:
8.1K
Avg. volume:
27.5K
1-year change:
-20.36%
Market cap:
$201.8M
Revenue:
$13.7M
EPS (TTM):
-$0.45
Earnings Data
Next earnings date for IPHA
Sep 17
2025
Most recent earnings per share
--
Missed by --
(May 31/2025)
Consensus Estimate
--
(May 31/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IPHA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2020 | Q4 | -- | -- | -- | -$0.17 | -- |
| 11/13/2019 | Q3 | -- | -- | -- | $0.05 | -- |
Innate Pharma SA Earnings Questions
-
How Much did Innate Pharma SA Generate in Revenue Last Quarter?
Innate Pharma SA reported -- worth of top line sales in its most recent quarter.
-
Did Innate Pharma SA Beat Earnings Last Quarter?
Innate Pharma SA announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Innate Pharma SA Profitable?
Innate Pharma SA reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Innate Pharma SA EPS Next Year?
Innate Pharma SA's earnings are forecast to decrease from -$0.66 per share to -- per share next year representing a decrease of -55.87%.
-
When is Innate Pharma SA's Earnings Date?
Innate Pharma SA's next earnings date is September 17, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
